BD211 Clinical Trials
3 recruitingGenetic
Not Applicable2Phase 11
Showing 1–3 of 3 trials
Recruiting
Phase 1
A Phase 1 Study of Gene-modified Autologous Hematopoietic Stem Cell (BD211) Treating β-thalassemia Major
Shanghai BDgene Co., Ltd.9 enrolled3 locationsNCT06465550
Recruiting
Not Applicable
Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent Beta-thalassemia
Shanghai BDgene Co., Ltd.10 enrolled1 locationNCT05773729
Recruiting
Not Applicable
Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent β-thalassemia
Shanghai BDgene Co., Ltd.10 enrolled1 locationNCT05776173